Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Circassia Pharmaceuticals ( (GB:NIOX) ) has issued an announcement.
NIOX Group plc announced that its Chief Operating Officer, Jonathan Emms, executed a financial transaction involving the company’s shares. On December 18, 2024, Emms sold 64,885 ordinary shares and subsequently repurchased 31,604 shares into his ISA at a higher price, while his spouse, Sharon Emms, also purchased 31,604 shares. These actions have resulted in Jonathan Emms holding a total of 941,669 shares, representing 0.23% of the company’s share capital. The transactions were conducted on the London Stock Exchange’s AIM market.
More about Circassia Pharmaceuticals
YTD Price Performance: -7.08%
Average Trading Volume: 929,095
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £244M
For an in-depth examination of NIOX stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- Eli Lilly’s (NYSE:LLY) Zepbound Shortage Over, Says FDA
- ‘The Boom Isn’t Over Yet,’ Says Top Investor About Ripple (XRP)
- TD Bank (TSE:TD) Gets Upgrade From BMO Capital
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
